Anand Shah, MD

Building companies that help patients. Cancer physician

[AtlanticLIVE @AtlanticLIVE]

AI won't replace physicians or that sacred patient-physician encounter, says @AsterInsights’ @AnandShahMD. But it will be a crucial adjunct to physicians in the future.

You can stream #PeopleVCancer in its entirety here: https://t.co/jusRtgOWM4

[Petrie-Flom Center @PetrieFlom]

Do you own your personal health data? Listen to @CohenProf, @AnandShahMD, @MichaelAbramoff, @ariezrawaldman and Cynthia Chauhan consider this question in the latest episode of #PetrieDishes. https://t.co/OvHH2FgiPn

[Anand Shah, MD @AnandShahMD]

Antimicrobial resistance has become a global public health crisis and emerging threat to national security. As with PEPFAR during the HIV/AIDS crisis and more recently the Covid pandemic, policy makers can spur bold new action to prevent the next superbug.

My op-ed in @thehill —

[TheHillOpinion @TheHillOpinion]

Congress should give superbugs the PEPFAR treatment https://t.co/lT7qOh1SXx

[Anand Shah, MD @AnandShahMD]

Enjoyed my conversation today with Tyler Mathisen at the @CNBCEvents #HealthyReturns Summit. We discussed the latest at the intersection of health policy, new cures, and global markets.

[CNBC Events @cnbcevents]

"At the current rate, Medicare is going to go bankrupt in about 5 years," Dr. @AnandShahFDA says at Healthy Returns, but also shares that value-based care could be the answer to solve this problem. #HealthyReturns

[Jeannie Baumann @jeanniereporter]

Medicare’s lecanmab/ aducanumab NCD shows how “it would behoove medical product developers to take into account both [CMS and FDA] upfront, a priori, during development,” @AnandShahMD

The latest from @cecelou18 and me

https://t.co/HvbtjZ8gix

[Marty Makary MD, MPH @MartyMakary]

Disappointing to see patients “who qualified for free care said they had been charged thousands of dollars and then harassed by collection agents. Many saw their credit scores ruined.” Some cut back on groceries to pay what Providence claimed they owed. https://t.co/Ub4RRoFVuY

[Anand Shah, MD @AnandShahMD]

In @statnews today, @mfarber429 and I discuss the impact of West Virginia v. EPA on FDA and tobacco regulation. Over the past quarter century, FDA has made tremendous progress towards curbing tobacco harm, but now more than ever Congress and FDA must work together on this mission

[STAT @statnews]

Opinion: Congress must keep building upon the progress it has made to provide the FDA with explicit authority to regulate e-cigarettes and other products associated with tobacco-related harm. https://t.co/2647CCkkFI

[Anand Shah, MD @AnandShahMD]

Great to speak with Senator @bfrist on the @ASOpodcast about the impact of Covid on healthcare innovation. Today's healthcare environment is changing at a rapid pace, with much constructive disruption of established paradigms.

#healthcare #innovation #covid #HealthTech

[Bill Frist, M.D. @bfrist]

New @asopodcast w/ fascinating FDA & CMS policy expert @AnandShahMD, who served as FDA’s Dep Commissioner for Medical & Scientific Affairs. We talk bringing new tech to market (& the federal modernization needed!), redesigning #healthcare delivery & more: https://t.co/f0BHk3wtIs

[Anand Shah, MD @AnandShahMD]

My @CNBC Op-Ed: Medicare seniors can't access many @US_FDA approved med devices. @CMSGov Medicare Coverage of Innovative Technology policy solves this dilemma in a balanced manner. CMS should enact this without further delay. Too many lives depend on it. https://t.co/RStAzfJxaH

[Health Affairs @Health_Affairs]

In their new blog, @ktkadakia and @AnandShahMD of @UniofOxford and @US_FDA outline how the operational and regulatory structures developed during #COVID19 represent a scalable model to accelerate biomedical innovation for antimicrobial resistance. https://t.co/DrLgpqHm01

[Zach Brennan @ZacharyBrennan]

Former head of FDA’s medical and scientific affairs on Covid: ‘FDA has never been tested like this’ - https://t.co/Eq6166WnxM